Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis (PEKASYS)
This study is currently recruiting participants.
Study NCT00332904   Information provided by Hvidovre University Hospital
First Received: May 31, 2006   Last Updated: July 18, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Cirrhosis
Portal Hypertension
Additional conditions recognized in this trial
Fibrosis
Hypertension
Hypertension, Portal
More general conditions related to this trial
Cardiovascular Diseases
Digestive System Diseases
Liver Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
propranolol
spironolactone
Additional drug interventions recognized in this trial
Adrenergic beta-Antagonists
Aldosterone Antagonists
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Antagonists
Anti-Arrhythmia Agents
Antihypertensive Agents
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Natriuretic Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Hvidovre University Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services